MDGL Madrigal Pharmaceuticals, Inc.
$440.33▲ +0.59%
Healthcare
Other
After hours
$440.33▲ +0.00%
Oct 27, 4:31 PM ET
Volume 209.6K
Avg Volume (10D) 300.6K
Key Metrics & Fundamentals
Market Cap
$10.17B
P/E Ratio
–
Div Yield
0.00%
52W Range
393.61 - 615.00
% vs 50 MA
-12.71%
% vs 200 MA
-12.12%
RSI-14
32.3
MACD Histogram
-1.3800
Beta (1Y vs SPY)
0.32
Free Cash Flow
$19.08M
Gross Rev
$364.25M
Gross Profit
$324.25M
EBITDA
-$49.62M
COGS
$40.01M
Operating Exp
$380.55M
Operating Income
-$56.31M
EBIT
-$56.31M
Pretax Income
-$57.94M
Net Income
-$57.94M
EPS (Diluted)
-1.99
Price & Volume History
Loading chart…
Recent News
Will Madrigal (MDGL) Report Negative Earnings Next Week? What You Should Know
Zacks · Oct 27, 2026 9:00 AM ET
Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH
GlobeNewswire · Oct 27, 2026 8:00 AM ET
Can Corcept Therapeutics Stock Rally 40% After This Dip?
Trefis · Oct 26, 2026 3:11 AM ET
Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026
GlobeNewswire · Oct 20, 2026 8:00 AM ET
BridgeBio, Madrigal, Cytokinetics Trade Lower Ahead of Q3 Results Amid Lack of Near-Term Catalysts, BofA Says
MT Newswires · Oct 19, 2026 11:42 AM ET
BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $533 From $543, Maintains Neutral Rating
MT Newswires · Oct 19, 2026 8:06 AM ET
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 15, 2026 4:05 PM ET
Madrigal Pharmaceuticals (MDGL) Genetics Update Keeps Fair Value In Focus
Simply Wall St. · Oct 8, 2026 11:16 AM ET
Madrigal Pharmaceuticals (MDGL) Stock Trades At A Discount Following A Very Large 5 Year Run
Simply Wall St. · Oct 8, 2026 8:14 AM ET
Is Rezdiffra’s Genetic-Risk Agnostic Data Reframing The Investment Case For Madrigal Pharmaceuticals (MDGL)?
Simply Wall St. · Oct 7, 2026 4:11 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MDGL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.